ACTINIUM AC-225 SATETRAXETAN-LYSINE
UNII 7CH33J3KMY

Substance Identification & Data

This profile provides standardized clinical and technical data for Actinium Ac-225 Satetraxetan-lysine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 7CH33J3KMY.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

7CH33J3KMY

CAS Registry Number

N/A

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ACTINIUM AC-225 SATETRAXETAN-LYSINE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C29H42N7O10S.Ac

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

CNKQUBHOTXVXTM-BEKLVUECSA-K

Line notation for describing the chemical structure and connectivity of atoms.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[225Ac+3].C1CN(CCN(C(c2ccc(NC(NCCCC[C@@H](C(=O)O)N)=S)cc2)CN(CCN1CC([O-])=O)CC(=O)[O-])CC(=O)O)CC(=O)[O-]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Actinium Ac-225 Satetraxetan-lysine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

ACTINIUM AC-225 DOTA-BENZYL-4-THIOCARBAMATE-LYSINE

ACTINIUM AC-225 DOTA-BNZ-LYSINE

ACTINIUM AC-225 SATETRAXETAN-LYSINE

External Clinical & Regulatory Resources

Previous UNII7CH18X4N1Y

Next UNII7CH5E50P0D